Evidence map›Paper›PMID 41814042›Full record

ArticleMolecular imaging and biology2026

Value of Imaging Parameters of [

Yihan Yan, Lifang Pang, Yibo He, Zhenghao Jiang, Yiqiu Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yihan Yan *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lifang Pang *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yibo HeDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhenghao JiangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yiqiu ZhangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. zhang.yiqiu@zs-hospital.sh.cn.

Funding

Science and Technology Commission of Shanghai Municipality 23TS1401300
6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the value of [

methodsThe study included 102 patients with ICC diagnosed between January 2018 and December 2022. All patients underwent preoperative [

resultsAmong the 102 patients with ICC, 60 (58.8%) patients had LNM while 42 patients (41.2%) were free of LNM. TBR(without LNM: 6.9 ± 3.6 vs. LNM: 8.2 ± 2.9, P = 0.019), CA19-9(506.9 ± 1602.7 vs. 1901.2 ± 3195.1, P = 0.011) and CEA(5.1 ± 8.9 vs. 32.5 ± 82.7, P = 0.035) in the LNM group were significantly higher than in the without LNM group. Three additional, statistically significant features, tumor TBR > 6.4, CA19-9 > 149.7 U/mL and CEA > 3.2 ng/mL, were integrated into a prediction model, which substantially outperformed use of the single parameter in ROC analysis (AUC 0.802 vs. 0.676, 0.671 and 0.656).

conclusionTBR > 6.4 and CA19-9 > 149.7 U/mL were identified as effective preoperative predictors of LNM in patients with ICC. The prognostic model we propose, integrating imaging parameters and serological indicators, significantly enhances predictive capability.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaFluorodeoxyglucose F18Lymphatic MetastasisPositron Emission Tomography Computed TomographyAgedFemaleHumansMaleMiddle AgedROC CurveFluorodeoxyglucose F18Intrahepatic cholangiocarcinomaLymph node metastasisPET/CTSerological index

Identifiers

PMID41814042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.